Condensed Consolidated Statements of Changes in Stockholders Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Comprehensive Income	Accumulated Deficit	Total
Balance at beginning of period at Dec. 31, 2020	$ 1	$ 73,732	$ 14	$ (66,544)	$ 7,203
Balance at beginning of period (shares) at Dec. 31, 2020	655,662
Increase (Decrease) in Stockholders' Equity
Issuance of common stock and warrants in connection with equity financing		10,000			10,000
Issuance of common stock and warrants in connection with equity financing (in shares)	83,338
Transaction costs in connection with equity financing		(908)			(908)
Stock-based compensation		187			187
Foreign currency translation adjustment			(7)		(7)
Net loss				(3,324)	(3,324)
Balance at end of period at Mar. 31, 2021	$ 1	83,011	7	(69,868)	13,151
Balance at end of period (shares) at Mar. 31, 2021	739,000
Balance at beginning of period at Dec. 31, 2020	$ 1	73,732	14	(66,544)	7,203
Balance at beginning of period (shares) at Dec. 31, 2020	655,662
Increase (Decrease) in Stockholders' Equity
Net loss					(10,706)
Balance at end of period at Sep. 30, 2021	$ 1	83,370	4	(77,250)	6,125
Balance at end of period (shares) at Sep. 30, 2021	742,810
Balance at beginning of period at Mar. 31, 2021	$ 1	83,011	7	(69,868)	13,151
Balance at beginning of period (shares) at Mar. 31, 2021	739,000
Increase (Decrease) in Stockholders' Equity
Stock-based compensation		180			180
Exercise of stock options		72			72
Exercise of stock options (in shares)	3,810
Foreign currency translation adjustment			(4)		(4)
Net loss				(3,921)	(3,921)
Balance at end of period at Jun. 30, 2021	$ 1	83,263	3	(73,789)	9,478
Balance at end of period (shares) at Jun. 30, 2021	742,810
Increase (Decrease) in Stockholders' Equity
Stock-based compensation		107			107
Foreign currency translation adjustment			1		1
Net loss				(3,461)	(3,461)
Balance at end of period at Sep. 30, 2021	$ 1	83,370	4	(77,250)	6,125
Balance at end of period (shares) at Sep. 30, 2021	742,810
Balance at beginning of period at Dec. 31, 2021	$ 1	96,420	4	(81,828)	14,597
Balance at beginning of period (shares) at Dec. 31, 2021	888,693
Increase (Decrease) in Stockholders' Equity
Stock-based compensation		207			207
Foreign currency translation adjustment			(1)		(1)
Net loss				(2,875)	(2,875)
Balance at end of period at Mar. 31, 2022	$ 1	96,627	3	(84,703)	11,928
Balance at end of period (shares) at Mar. 31, 2022	888,693
Balance at beginning of period at Dec. 31, 2021	$ 1	96,420	4	(81,828)	14,597
Balance at beginning of period (shares) at Dec. 31, 2021	888,693
Increase (Decrease) in Stockholders' Equity
Net loss					(9,291)
Balance at end of period at Sep. 30, 2022	$ 1	97,056		(91,119)	5,938
Balance at end of period (shares) at Sep. 30, 2022	888,693
Balance at beginning of period at Mar. 31, 2022	$ 1	96,627	3	(84,703)	11,928
Balance at beginning of period (shares) at Mar. 31, 2022	888,693
Increase (Decrease) in Stockholders' Equity
Stock-based compensation		211			211
Foreign currency translation adjustment			$ (3)		(3)
Net loss				(3,303)	(3,303)
Balance at end of period at Jun. 30, 2022	$ 1	96,838		(88,006)	8,833
Balance at end of period (shares) at Jun. 30, 2022	888,693
Increase (Decrease) in Stockholders' Equity
Stock-based compensation		218			218
Net loss				(3,113)	(3,113)
Balance at end of period at Sep. 30, 2022	$ 1	$ 97,056		$ (91,119)	$ 5,938
Balance at end of period (shares) at Sep. 30, 2022	888,693